Table 3:

Methods of TAS and angiographic results in the occlusion group

Patient/Sex/Age (y)No. of Used StentsDose of Urokinase*Preprocedure/Postprocedure TIMIPrestenosis/Poststenosis (%)Technical SuccessProcedural Dissections or Clots
1/M/57300/3100/10SuccessYes
2/M/72100/3100/5SuccessYes
3/M/63300/3100/30SuccessYes
4/M/750120/3100/40SuccessNo
5/F/620240/0100/100FailureNE
6/F/730420/0100/100FailureNE
7/M/74000/3100/45SuccessNo
8/M/770120/3100/20SuccessNo
9/M/84100/3100/10SuccessYes
10/F/74000/3100/40SuccessNo
11/M/74100/0100/100FailureYes
12/M/63000/3100/10SuccessNo
13/F/76300/3100/8SuccessYes
14/F/81000/3100/10SuccessNo
15/F/71100/3100/25SuccessYes
16/F/60000/3100/20SuccessNo
  • Note:—TAS indicates transluminal angioplasty and/or stenting; NE, no evaluation; M, male; F, female; TIMI, Thrombolysis in Myocardial Infarction.

  • * Data are ×104 units.

  • Grading with the TIMI definitions, 0 indicates no perfusion; 1, penetration without perfusion; 2, partial perfusion; and 3, complete perfusion.

  • Preprocedural and postprocedural stenotic ratio was measured with the warfarin-aspirin symptomatic intracranial disease method.